Effects of granisetron in the treatment of nausea and vomiting after laparoscopic cholecystectomy: A dose-ranging study

Clinical Therapeutics

Volumn 26, Issue 7, 2004, Pages 1055-1060

  Fujii, Yoshitaka ^a,c   Tanaka, Hiroyoshi ^b   Kawasaki, Tsuneo ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

antiemetic; granisetron; laparoscopic cholecystectomy; nausea; vomiting

Indexed keywords

FENTANYL; GRANISETRON; ISOFLURANE; NITROUS OXIDE; PLACEBO; THIOPENTAL; VECURONIUM;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHOLECYSTECTOMY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEMOGRAPHY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MONITORING; DRUG TOLERABILITY; EXPERIENCE; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL ANESTHESIA; HEADACHE; HEALTH STATUS; HOSPITAL DEPARTMENT; HUMAN; JAPAN; MALE; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIEMETICS; CHOLECYSTECTOMY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GRANISETRON; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; TREATMENT OUTCOME;

EID: 4344716572     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)90177-4     Document Type: Article

References (10)

1. Santon J.M. Anesthesia for laparoscopic cholecystectomy. Anaesthesia. 46:1991;317. Letter
2. Iitomi T., Toriumi S., Kondo A., et al. Incidence of nausea and vomiting after cholecystectomy performed via laparotomy or laparoscopy. [in Japanese] Masui (Jpn J Anesthesiol). 44:1995;1627-1631
3. Watcha M.F., White P.F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 77:1992;161-184
4. Bermudez J., Boyle E.A., Miner W.D., Sanger G.J. The anti-emetic potential of the 5-hydroxytryptamine 3 receptor antagonist BRL 43694. Br J Cancer. 58:1988;644-650
5. Cassidy J., Raina V., Lewis C., et al. Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist. Br J Cancer. 58:1988;651-653
6. 3 receptor antagonist: Correlation of anti-emetic response. Cancer Chemother Pharmacol. 24:1989;45-49
7. Fujii Y., Tanaka H., Kawasaki T. Randomized clinical trial of granisetron, droperidol and metoclopramide for the treatment of nausea and vomiting after laparoscopic cholecystectomy. Br J Surg. 87:2000;285-288
8. Yarker Y.E., McTavish D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplasmic therapy. Drugs. 48:1994;761-793
9. Fleischer L.A. Perioperative evaluation. Barash P.G., Cullen B.F., Stoelting R.K. Clinical Anesthesia. 3rd ed. :1996;443-459 Lippincott-Raven, Philadelphia, Pa
10. McCormick C.G. FDA alert: Current FDA report on droperidol status and basis for "Black Box" warning. ASA Newsl. 66:2002;19